Results 221 to 230 of about 24,701 (248)
Some of the next articles are maybe not open access.
Injectable Contraception with Depot Medroxyprogesterone Acetate
Drugs, 1993Depot medroxyprogesterone acetate (DMPA) the only injectable contraception approved in the United States in 1992 is used by 8-9 million women in more than 90 countries. DMPA inhibits ovulation by the reduction of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) plasma levels.
Andrew M, Kaunitz, Allan, Rosenfield
openaire +2 more sources
A potential mechanism in medroxyprogesterone acetate teratogenesis
Teratology, 1979AbstractMedroxyprogesterone acetate (MPA) has been shown to be teratogenic in rabbits but not in rats or mice (Andrew and Staples, 1977). Since normal steroid action appears to be mediated, in large part, through interaction with specific steroid receptors, we postulated that the species difference in teratogenicity might be due to a difference in the ...
G L, Kimmel, B S, Hartwell, F D, Andrew
openaire +2 more sources
Depot Medroxyprogesterone Acetate and Adolescents
Clinical Journal for Nurse Practitioners in Women's HealthDepot medroxyprogesterone acetate (DMPA) is an effective method of contraception that may be underutilized due to lack of information or access. This article updates clinicians on current evidence about the safety and potential side effects of DMPA.
Eva Fried, Mandi Lew, Maria Mock
openaire +1 more source
Depot medroxyprogesterone acetate pioneers
Contraception, 1997Linda S. Potter +3 more
openaire +1 more source